Literature DB >> 16239312

The hypothalamus-pituitary-ovary axis and type 1 diabetes mellitus: a mini review.

R F Arrais1, S A Dib.   

Abstract

A high prevalence of menstrual cycle and fertility disturbances has long been associated with diabetes mellitus. However, rationalization of the intrinsic mechanisms of these alterations is controversial and even contradictory. This review considers (i) the relationship between diabetes mellitus, especially type 1 diabetes mellitus (T1DM), and the hypothalamus-pituitary-ovary (HPO) axis, (ii) the state of our knowledge concerning neuroendocrine control and its relationship with dopaminergic and opioid tonus, and (iii) the influence of the hypothalamus-pituitary-adrenal axis on ovarian function. Functional disturbances that occur as a consequence of diabetes are also discussed, but some T1DM-related diseases of autoimmune origin, such as oophoritis, are not further analysed. Although there are clear indications of a relationship between menstrual and fertility alterations and glycaemic control, in many instances the improvement of the latter is not sufficient to reverse such alterations. It appears that the oligoamenorrhoea and amenorrhoea associated with T1DM is mainly of hypothalamic origin (i.e. failure of the GnRH pulse generator) and may be reversible. The importance of the evaluation of the HPO axis in T1DM women with menstrual irregularities, even in the presence of adequate metabolic control, is emphasized.

Entities:  

Mesh:

Year:  2005        PMID: 16239312     DOI: 10.1093/humrep/dei353

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  10 in total

1.  Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study.

Authors:  C Kim; R S Miller; B H Braffett; Y Pan; V L Arends; A K Saenger; A Barnie; A V Sarma
Journal:  Clin Endocrinol (Oxf)       Date:  2018-01-26       Impact factor: 3.478

2.  Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis.

Authors:  Zhaozhong Zhu; Yifei Lin; Xihao Li; Jane A Driver; Liming Liang
Journal:  Hum Genet       Date:  2019-02-25       Impact factor: 4.132

3.  Adiponectin to the rescue: how the embryo maintains glucose uptake in a diabetic mother.

Authors:  Romana A Nowak
Journal:  Endocrinology       Date:  2013-07       Impact factor: 4.736

4.  Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI.

Authors:  Nutsa Aladashvili-Chikvaidze; Jenara Kristesashvili; Manana Gegechkori
Journal:  Iran J Reprod Med       Date:  2015-03

5.  Menstrual Disturbances in Premenopausal Women with End-Stage Renal Disease: A Cross-Sectional Study.

Authors:  Chong-Ting Lin; Xi-Ning Liu; Hong-Lei Xu; Hui-Yan Sui
Journal:  Med Princ Pract       Date:  2016-02-23       Impact factor: 1.927

Review 6.  Effects of Low Energy Availability on Reproductive Functions and Their Underlying Neuroendocrine Mechanisms.

Authors:  Takeshi Iwasa; Toshiya Matsuzaki; Kiyohito Yano; Yiliyasi Mayila; Rie Yanagihara; Yuri Yamamoto; Akira Kuwahara; Minoru Irahara
Journal:  J Clin Med       Date:  2018-07-05       Impact factor: 4.241

7.  Gender differences in adverse event reports associated with antidiabetic drugs.

Authors:  Kyung-In Joung; Gyu-Won Jung; Han-Heui Park; Hyesung Lee; So-Hee Park; Ju-Young Shin
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

Review 8.  Effects of low energy availability on female reproductive function.

Authors:  Takeshi Iwasa; Saki Minato; Junki Imaizumi; Atsuko Yoshida; Takako Kawakita; Kanako Yoshida; Yuri Yamamoto
Journal:  Reprod Med Biol       Date:  2021-09-20

Review 9.  Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging.

Authors:  Meng Wu; Yican Guo; Simin Wei; Liru Xue; Weicheng Tang; Dan Chen; Jiaqiang Xiong; Yibao Huang; Fangfang Fu; Chuqing Wu; Ying Chen; Su Zhou; Jinjin Zhang; Yan Li; Wenwen Wang; Jun Dai; Shixuan Wang
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

10.  Insulin-like growth factor 1 mRNA expression in the uterus of streptozotocin-treated diabetic mice.

Authors:  Yoshie Manabe; Makoto Tochigi; Akiyoshi Moriwaki; Sakae Takeuchi; Sumio Takahashi
Journal:  J Reprod Dev       Date:  2013-05-30       Impact factor: 2.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.